.png)
15th Annual Drug Discovery
Innovation Forum 2024
For the patients, we must do better.
LEADERS SHAPING THE FUTURE
ADVISORY
“Our very survival depends on our ability to stay awake, to adjust to new ideas, to remain vigilant and to face the challenge of change.” – Martin Luther King ...
GDDIF was formed 15 years ago and our mission remains the same to push the boundaries to affect change, for the patients.
To continue this statement drug discovery to development must evolve towards ML, AR, Generative AI and LLM - there is no avoiding it. To truly embrace the new era that we are embarking on we must overcome barriers to implementation.
In order to continue delivering life-changing therapies to patients we must work together, break away from silos and integrate upcoming innovations. By bringing together experts, leaders and academics - past, present and future together we can remove the barriers. Collaborate, innovate and evolve - to serve the purpose in unison.
Stevan Djuric
Adjunct Professor at The University of Kansas - Previous Vice President of Abbvie
Thomas Herget
Head Silicon Valley & China Innovation Hub at Merck Group
Ted Torphy
Senior Pharmaceutical R&D Executive
Uli Schmitz
Senior Director, Structural Chemistry at Gilead Sciences
John Wise
Executive Director of the Pistoia Alliance
Werngard Czechtizky
Executive Director Head Medicinal Chemistry, Respiratory and Immunology at AstraZeneca
Uwe Gottschalk
Operating Partner at Keensight Capital
Jens H. Vogel
SVP and Global Head of Biotech at Bayer Pharmaceuticals
CONFIRMED SPEAKERS 2024
The Journey Continues
PREVIOUS GDDIF SPEAKERS
2024 PROGRAMME SNAPSHOT
The much-awaited 15th Annual Drug Discovery Innovation Forum #DDIF is an exclusive two-day in-person-only summit on the 4th and 5th of September at The Hotel Palace Berlin. Here, you will hear from CxOs, decision-makers and industry leaders who are transforming the future of drug discovery and development. Listen to experts, gain knowledge and collaborate to acquire strategies to support your processes. Learn from their previous failures and avoid difficulties by breaking down traditional data gatekeeping to advance.
Technological advancements across the biopharmaceutical sector boost the drive towards more precision therapies. Increased LLM, AR, AI and machine learning efficiency, including automation, will revolutionise the healthcare system. To unlock the full potential we must have a solid foundation of accurate data.
As this new age of drug development continues to evolve, we must collaborate and share the knowledge we have learnt and not remain in our own silos.
KEY TOPICS
-
The future of AI & ML in Drug Discovery
-
Bioinformatic innovation
-
Insights into generative AI and Chat GPT
-
Neural networks, digital twins and drug designs
-
Advances in-silico modelling
-
Quantum technologies and AI applications
BIOINNOVATION TRACK
-
CRO/CDMO with biopharma data collection
-
Improve clinical outcomes - step away from data silos
-
Digitisation of biologics in R&D by exploring analytics
JOURNEY OF A CXO
-
World-renowned speakers
-
Curated plenary sessions
-
Journey, lessons learnt and the evolution
WHY ATTEND
Engage in thought-provoking discussions on challenges and opportunities facing the drug discovery industry
Revolutionize R&D through AI & Machine Learning
In-Person only attendance of up to 200 decision-makers
Maximise your time by taking part in our exclusive pre-qualified one-to-one networking service
Hear exclusively from renowned leaders presenting on challenges when leveraging digital technologies, artificial intelligence, and machine learning in your innovation cycle
Leveraging AI to unblock drug discovery, drug repurposing and target validation
Explore the latest advancements, breakthroughs, and innovative approaches in the quest for new drugs and therapies
Uncover novel therapeutics targets, drug candidates, and innovative approaches that can drive the development of life-changing treatments
Journey of a CXO - witness in person The Why? The journey and destination of some of the most inspirational CXO’s in the industry
“Success in creating AI would be the biggest event in human history. Unfortunately, it might also be the last, unless we learn how to avoid the risks.”
- Nick Bostrom
INNOVATION SPOTLIGHT
-
Big data analytics and real-world evidence
-
Bridging the gap between automation and innovation
-
Drug discovery by using AI and ML
WHY ATTEND
-
In-person only
-
Pre-qualified attendance
-
One-to-one meetings
VENDOR FOCUS
-
CROs
-
Software
-
Robotics and Automation
-
Bioinformatics, Big Data Analytics and Integration
-
AI-powered Target Identification
-
Genomic and Proteomics
250+
Up to 250 decision-makers in person. Previous attendee demographics include 50% EMEA, 30% America and 20% ROW
20%
20% best-of-breed vendors supporting the drug discovery industry
06
Journey of CXO presentations. Six insightful, powerful and inspirational talks from CXOs in the industry
02
Exclusive in-person networking, over 2 days in Berlin on the 4th & 5th of September 2024
7+
Pre-scheduled and pre-qualified one-to-one meetings with delegates who can either influence or make a decision
90%
Over 90% of our attendance provided positive feedback. Please click here to see what our delegation has to say
THE NUMBERS
Type of Job Titles Attending:
-
CEO
-
CSO
-
CTO
-
CIO
-
EVP/SVP/VP
-
Director
Type of Companies Attending:
-
Pharmaceutical Organizations
-
Pharma and Research Institutions
-
Contract Development and Manufacturing Organizations
-
Government and Regulatory Agencies
-
Biotech Companies
-
Drug Discovery Solution Providers
-
Digital health and software providers
-
Logistics and supply chain companies
INVITE ONLY LEADERS SUMMIT
AUDIENCE IN PERSON ONLY
DDIF
